The Latest Breaking News from NYSE

Shares of airline companies, including United Airlines Holdings Inc (NASDAQ: UAL), are trading higher in sympathy with Delta Air Lines (NYSE: DAL), which reported better-than-expected first-quarter EPS results.

General Electric (NYSE:GE) will host a conference call at 08:00 AM ET on April 26, 2022, to discuss Q1 2022 earnings results. How to Attend General Electric (GE) Conference Call Follow this link to access the live webcast.

Analysts have provided the following ratings for Albertsons Companies (NYSE:ACI) within the last quarter:

The long stretch of historically low interest rates may have benefited real estate more than any other sector. Cheap debt has a direct impact on cash flow, which means more capital to grow and more cash to distribute to shareholders.

Shaw Communications Inc (NYSE:SJR) reported a second-quarter FY22 revenue decline of 2% year-on-year to C$1.36 billion. EPS was C$0.39. Adjusted EBITDA declined 0.8% to C$632 million, and the margin expanded by 60 bps to 46.5%. Wireline revenue decreased 1.3% Y/Y to C$1.04 billion, and Wireless revenue decreased 3.9% to C$323 million. The Wireless…

On CNBC’s “Halftime Report Final Trades,” Jon Najarian chose Vertical Aerospace Ltd (NYSE: EVTL).

Shares of Cameco Corp (NYSE: CCJ) Tuesday climbed over 1% on Tuesday, adding to recent gains and taking the stock higher by more than 36% year to date.

Ark Invest, the fund run by Cathie Wood, has been gradually trimming its position in Twitter, Inc. (NYSE: TWTR) since the start of the year.

GlaxoSmithKline plc (NYSE:GSK) has agreed to acquire Sierra Oncology Inc (NASDAQ:SRRA) for $55 per share in cash, representing an approximate total equity value of $1.9 billion (£1.5 billion). Sierra's momelotinib complements GSK's Blenrep (belantamab mafodotin), building on GSK's commercial and medical expertise in hematology.  If momelotinib is approved, GSK expects momelotinib will contribute to GSK's growing…